Cytosorbents Corp Form 8-K Summary
Business Context and Reporting Period
Cytosorbents Corporation (CTSO), a Delaware corporation, filed this Form 8-K on March 25, 2026. The filing announces the release of financial results for the quarter and full year ended December 31, 2025. The company's principal executive offices are located in Princeton, New Jersey.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
No material changes versus prior periods are detailed in the filing text. The document serves solely as a notification that the results for the period ended December 31, 2025, have been issued.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, management commentary, risk factors, or details on unusual items. It incorporates by reference the information in the press release (Exhibit 99.1) under Regulation FD.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 25, 2026) for actual revenue, net income, and cash flow figures.
- Verify year-over-year growth rates and margin trends for the quarter and year ended December 31, 2025.
- Check for any updated forward-looking guidance or operational milestones mentioned in the press release.
- Confirm the company's liquidity position and debt obligations as disclosed in the full earnings release.